DK1231211T3 - Thiazolidindion-derivater som antidiabetika - Google Patents

Thiazolidindion-derivater som antidiabetika

Info

Publication number
DK1231211T3
DK1231211T3 DK00974559T DK00974559T DK1231211T3 DK 1231211 T3 DK1231211 T3 DK 1231211T3 DK 00974559 T DK00974559 T DK 00974559T DK 00974559 T DK00974559 T DK 00974559T DK 1231211 T3 DK1231211 T3 DK 1231211T3
Authority
DK
Denmark
Prior art keywords
antidiabetic agents
thiazolidinedione derivatives
thiazolidinedione
derivatives
antidiabetic
Prior art date
Application number
DK00974559T
Other languages
English (en)
Inventor
Mancini Marisabel Mourelle
Castillo Nieto Juan Carlos Del
Ramon Amat Elisabet De
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Application granted granted Critical
Publication of DK1231211T3 publication Critical patent/DK1231211T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00974559T 1999-11-18 2000-11-15 Thiazolidindion-derivater som antidiabetika DK1231211T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos
PCT/ES2000/000432 WO2001036416A1 (es) 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (1)

Publication Number Publication Date
DK1231211T3 true DK1231211T3 (da) 2003-10-27

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00974559T DK1231211T3 (da) 1999-11-18 2000-11-15 Thiazolidindion-derivater som antidiabetika

Country Status (37)

Country Link
US (1) US7001910B1 (da)
EP (1) EP1231211B1 (da)
JP (1) JP2003514817A (da)
KR (1) KR100518110B1 (da)
CN (1) CN1159314C (da)
AP (1) AP1330A (da)
AR (1) AR031080A1 (da)
AT (1) ATE241622T1 (da)
AU (1) AU770045B2 (da)
BG (1) BG106699A (da)
BR (1) BR0015613A (da)
CA (1) CA2391913A1 (da)
CO (1) CO5261560A1 (da)
CR (1) CR6640A (da)
CZ (1) CZ20021654A3 (da)
DE (1) DE60003072T2 (da)
DK (1) DK1231211T3 (da)
EA (1) EA004301B1 (da)
EE (1) EE200200254A (da)
ES (2) ES2156574B1 (da)
GE (1) GEP20043240B (da)
HR (1) HRP20020426A2 (da)
HU (1) HUP0203478A2 (da)
IL (1) IL149634A0 (da)
IS (1) IS2014B (da)
MA (1) MA26844A1 (da)
MX (1) MXPA02005011A (da)
NO (2) NO20022336L (da)
NZ (1) NZ519264A (da)
OA (1) OA12089A (da)
PE (1) PE20010858A1 (da)
PL (1) PL354877A1 (da)
PT (1) PT1231211E (da)
SK (1) SK6752002A3 (da)
WO (1) WO2001036416A1 (da)
YU (1) YU40202A (da)
ZA (1) ZA200203906B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) * 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
YU40202A (sh) 2006-01-16
EE200200254A (et) 2003-06-16
MA26844A1 (fr) 2004-12-20
KR100518110B1 (ko) 2005-10-04
OA12089A (en) 2006-05-04
ATE241622T1 (de) 2003-06-15
JP2003514817A (ja) 2003-04-22
WO2001036416A1 (es) 2001-05-25
NO20022379D0 (no) 2002-05-16
DE60003072T2 (de) 2004-04-01
AU770045B2 (en) 2004-02-12
MXPA02005011A (es) 2003-10-14
BR0015613A (pt) 2002-07-23
ES2156574A1 (es) 2001-06-16
GEP20043240B (en) 2004-05-25
EA200200470A1 (ru) 2002-10-31
PT1231211E (pt) 2003-09-30
IS2014B (is) 2005-06-15
NZ519264A (en) 2003-10-31
CO5261560A1 (es) 2003-03-31
AR031080A1 (es) 2003-09-10
NO20022336L (no) 2002-07-09
IL149634A0 (en) 2002-11-10
ES2156574B1 (es) 2002-02-01
ES2199878T3 (es) 2004-03-01
HRP20020426A2 (en) 2004-02-29
BG106699A (bg) 2003-02-28
EA004301B1 (ru) 2004-02-26
DE60003072D1 (de) 2003-07-03
CA2391913A1 (en) 2001-05-25
PL354877A1 (en) 2004-03-08
AU1281501A (en) 2001-05-30
CN1402724A (zh) 2003-03-12
IS6386A (is) 2002-05-15
HUP0203478A2 (hu) 2003-02-28
KR20020079737A (ko) 2002-10-19
AP2002002512A0 (en) 2002-06-30
CR6640A (es) 2004-03-05
EP1231211A1 (en) 2002-08-14
US7001910B1 (en) 2006-02-21
NO20022336D0 (no) 2002-05-15
ZA200203906B (en) 2004-03-26
CZ20021654A3 (cs) 2002-09-11
CN1159314C (zh) 2004-07-28
AP1330A (en) 2004-11-25
PE20010858A1 (es) 2001-08-22
SK6752002A3 (en) 2002-09-10
EP1231211B1 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
NO20041567L (no) 1,8-nafthyridinderivater som antidiabetiske midler
EE200200273A (et) Uudsed diabeedivastased agensid
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20013559D0 (no) Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler
NO20025978D0 (no) Benzotiazol-derivater
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
NO20041317L (no) Benzimidazolidinondenvater som muskarine midler
NO20006071D0 (no) Isotiazolderivater nyttige som anti-cancer midler
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
PT1237857E (pt) Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de) Propargyletherderivate
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
ATE273272T1 (de) Mevinolinderivate
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
DK1144431T3 (da) 16-Hydroxyestratriener som selektivt aktive estrogener
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
NO20020457D0 (no) Benzenaminderivater som antikoagulanter
DK1075471T3 (da) Idolylderivater som serotonerge midler
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
TR200002831A3 (tr) Kinolin-4-Il türevleri I
NO993812L (no) (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler
DK1073651T3 (da) Indolylderivater som serotonerge midler
ATE269328T1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
DE60006104D1 (de) Cinnamoylaminoalkyl-substituierte benzenesulfonamid-derivate